Form Type: 4

SEC EDGAR Link
Acccession Number:0001104659-19-045962
Date:2019-08-12
Issuer: AMPHASTAR PHARMACEUTICALS, INC. (AMPH)
Original Submission Date:

Reporting Person:

LIAWATIDEWI YAKOB
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET RANCHO CUCAMONGA, CA 91730

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-08-12 M 5,000 a $10.93 47,188 direct
COMMON STOCK 2019-08-12 S 10,518 d $20.44 36,670 direct
COMMON STOCK 2019-08-13 M 5,000 a $10.93 41,670 direct
COMMON STOCK 2019-08-13 S 5,000 d $20.73 36,670 direct
COMMON STOCK 0 $0.00 6,369 indirect f4
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 10.93 2019-08-12 deemed execution date M 5,000 (d) 2023-07-30 common stock 5,000 $10.93 21,000 direct
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 10.93 2019-08-13 deemed execution date M 5,000 (d) 2023-07-30 common stock 5,000 $10.93 16,000 direct
Footnotes
IDfootnote
f1 the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 13, 2018.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $20.38 to $20.49, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this form 4.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $20.72 to $20.75, inclusive.
f4 the reported shares are held of record by the yakob and sunmoon trust dated july 25, 2013 for which the reporting person serves as a trustee.
f5 shares subject to the option are fully vested and immediately exercisable.

Elevate your investments